MC2300A1 - Procede de preparation d'un facteur de necrose tumorale humaine - Google Patents

Procede de preparation d'un facteur de necrose tumorale humaine

Info

Publication number
MC2300A1
MC2300A1 MC912217A MC2217A MC2300A1 MC 2300 A1 MC2300 A1 MC 2300A1 MC 912217 A MC912217 A MC 912217A MC 2217 A MC2217 A MC 2217A MC 2300 A1 MC2300 A1 MC 2300A1
Authority
MC
Monaco
Prior art keywords
preparation
necrosis factor
tumor necrosis
human tumor
human
Prior art date
Application number
MC912217A
Other languages
English (en)
French (fr)
Inventor
Fiers Walter
Tavernier Jan
Van Ostade Xaveer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2300A1 publication Critical patent/MC2300A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MC912217A 1990-11-21 1991-11-18 Procede de preparation d'un facteur de necrose tumorale humaine MC2300A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90810901 1990-11-21

Publications (1)

Publication Number Publication Date
MC2300A1 true MC2300A1 (fr) 1993-09-06

Family

ID=8205969

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912217A MC2300A1 (fr) 1990-11-21 1991-11-18 Procede de preparation d'un facteur de necrose tumorale humaine

Country Status (17)

Country Link
US (2) US5422104A (es)
EP (1) EP0486908A3 (es)
JP (1) JPH06256395A (es)
AR (1) AR245783A1 (es)
AU (1) AU655948B2 (es)
CA (1) CA2055168A1 (es)
FI (1) FI915379A (es)
HU (1) HUT62034A (es)
IE (1) IE914035A1 (es)
IL (1) IL100062A0 (es)
MC (1) MC2300A1 (es)
MX (1) MX9102110A (es)
NO (1) NO914541L (es)
NZ (1) NZ240595A (es)
PT (1) PT99560A (es)
UY (1) UY23327A1 (es)
ZA (1) ZA919035B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK376492A3 (en) * 1992-04-02 1995-06-07 Hoffmann La Roche Tnf - muteins and method of their production
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP1069917A4 (en) * 1998-03-20 2005-02-09 Genzyme Corp NEW COMPLEMENTARY PAIRS OF RECEPTORS / LIGANDS AND ADOPTIVE IMMUNOTHERAPY USING THE SAME
ATE329610T1 (de) * 2000-02-16 2006-07-15 Genentech Inc Anti-april antikörper und hybridomazellen
US7244823B2 (en) * 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7687461B2 (en) 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
CN1636067A (zh) * 2001-08-03 2005-07-06 杰南技术公司 TACls和BR3多肽及其用途
US20030086903A1 (en) * 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
CN1692127A (zh) * 2002-07-25 2005-11-02 健泰科生物技术公司 Taci抗体及其用途
AU2003298816C1 (en) * 2002-12-02 2010-12-16 Amgen Fremont, Inc. Antibodies directed to Tumor Necrosis Factor and uses thereof
US20050163775A1 (en) * 2003-06-05 2005-07-28 Genentech, Inc. Combination therapy for B cell disorders
US20050095243A1 (en) * 2003-06-05 2005-05-05 Genentech, Inc. Combination therapy for B cell disorders
JP2007511507A (ja) * 2003-11-14 2007-05-10 ジェンベク、インコーポレイティッド 癌を処置するための治療レジメン
TW200526780A (en) * 2004-01-06 2005-08-16 Hayashibara Biochem Lab TNF antagonists and TNF inhibitors comprising the same as the active ingredient
EP1598075A1 (en) * 2004-05-21 2005-11-23 LEK Pharmaceuticals d.d. Process for the isolation and / or purification of proteins
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
EP1846039A2 (en) * 2005-01-10 2007-10-24 Research Development Foundation Targeted chimeric molecules for cancer therapy
CA2629306A1 (en) * 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
US11535673B2 (en) * 2007-04-05 2022-12-27 President and Fellows of Harvard CoHege Chimeric activators: quantitatively designed protein therapeutics and uses thereof
US9605844B2 (en) * 2009-09-01 2017-03-28 Cree, Inc. Lighting device with heat dissipation elements
WO2014124134A1 (en) 2013-02-07 2014-08-14 The General Hospital Corporation Methods for expansion or depletion of t-regulatory cells
EP3139955B1 (en) 2014-04-30 2024-03-20 President and Fellows of Harvard College Fusion proteins for treating cancer and related methods
US11103592B2 (en) 2016-11-09 2021-08-31 Philogen S.P.A. IL2 and TNF mutant immunoconjugates
EP4204094A1 (en) 2020-08-27 2023-07-05 Enosi Therapeutics Corporation Methods and compositions to treat autoimmune diseases and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851626B (es) * 1984-07-05 1985-11-26 Genentech Inc
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
ATE107362T1 (de) * 1986-06-20 1994-07-15 Dainippon Pharmaceutical Co Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
AU1346488A (en) * 1987-02-26 1988-09-26 Cetus Corporation Arginine-depleted human tumor necrosis factor
JPS63291590A (ja) * 1987-05-25 1988-11-29 Teijin Ltd 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide

Also Published As

Publication number Publication date
JPH06256395A (ja) 1994-09-13
EP0486908A3 (en) 1992-11-19
PT99560A (pt) 1992-10-30
AR245783A1 (es) 1994-02-28
HUT62034A (en) 1993-03-29
FI915379A (fi) 1992-05-22
NO914541D0 (no) 1991-11-20
MX9102110A (es) 1992-07-08
IE914035A1 (en) 1992-06-03
AU655948B2 (en) 1995-01-19
ZA919035B (en) 1992-08-26
FI915379A0 (fi) 1991-11-14
AU8791591A (en) 1992-05-28
EP0486908A2 (en) 1992-05-27
US5422104A (en) 1995-06-06
CA2055168A1 (en) 1992-05-22
HU913595D0 (en) 1992-01-28
US5652353A (en) 1997-07-29
IL100062A0 (en) 1992-08-18
NO914541L (no) 1992-05-22
NZ240595A (en) 1994-09-27
UY23327A1 (es) 1992-05-19

Similar Documents

Publication Publication Date Title
MC2300A1 (fr) Procede de preparation d'un facteur de necrose tumorale humaine
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
MA22668A1 (fr) Procede de preparation d'oxamides .
MA22894A1 (fr) Procede de preparation d'un vaccin.
ES515032A0 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
IL91014A0 (en) Magnetic treatment of water used for agricultural purposes
MC1553A1 (fr) Proteine d'interferon immunitaire humain et son procede de production
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
MA21854A1 (fr) Procede de preparation de phosphonomethyl thioethoxypurines .
GB2255506B (en) Fish food composition for the prevention/treatment of diseases
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
ZA914435B (en) Treatment of disease
FR2620702B1 (fr) Procede de preparation d'irones naturelles
FR2659652B1 (fr) Procede de preparation de n-phenyl benzoquinone-imine.
FR2666965B1 (fr) Procede de preparation d'extrait concentre d'algues.
EP0469359A3 (en) Method and product for the treatment of gastric disease
FR2643902B1 (fr) Procede de preparation de n-allylmetatrifluoromethylaniline
EP0460544A3 (en) Process for the preparation of sulphonated anthranilic acids
AU7999691A (en) Phthalamic acids and their isomers for treating leukotriene-related diseases
PT85076A (en) Method for the treatment of infections disease by administration of tumor necrosis factor-alpha
MX10085A (es) Procedimiento para la preparacion de 4-arilcarbonil-1-((4-morfolinil)-alquilo-inferior)-1h-indoles y producto obtenido.
FR2663320B1 (fr) Procede de preparation de dialcoxybutenes.
FR2627488B1 (fr) Procede de preparation d'acides difluorocarboxyliques